[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: FpML-BP minutes 5/23
"3. Generic product: GS uses a very skinny representation for complex
products"
Please can you provide more context
Do you mean a view on the product earlier in life, such as sales,
structuring, or termsheet ?
Regards
Andrew Parry
+44 20 7325 1486
Exotics and Hybrids Modelling
JP Morgan
"Marc Gratacos" <MGratacos@xxxxxxxx>
Sent by: bpwg@xxxxxxxx
29/05/2007 11:28
Please respond to
bpwg@xxxxxxxx
To
<bpwg@xxxxxxxx>
cc
Subject
FpML-BP minutes 5/23
Present
=======
Brian Lynn (GEM)
Irina Yermakova (ISDA)
Michael Fitzgerald (SWIFT)
Pierre Lamy (GS)
Vinod Jain (Wipro)
Christian Unger (BBH)
John Booth (Northern Trust)
Steve Ross-Talbot (Hattrick)
Marc Gratacos (ISDA), chair
Minutes
=======
Review of Actions
1. Review of actions
>>> Action (OPEN): MG to document scenarios where lack of message
rejected/timeout for cash flow matching messages this is required.
>>> Action (OPEN): IY to propose a message or messages for responding to
a request or a notification, with the ability to:
- indicate that the message was received (but not necessarily processed)
- indicate that the message was processed successfully.
>>> Action: BL/MG to document that generic product is intended to be
used only for portfolio composition reporting and reconciliation
(deferred to Generic Product discussion)
>>> Action (DONE): BL to identify the new fields that would be required
to meet the list in the spreadsheet for the portfolio reconciliation
data standards (attached)
>>> Action (DONE): IY circulate the existing portfolio reconciliation
Documentation
2. Product types: disagreement on the fact that the Validation Working
doesn't agree to include product type rules as validation rules. These
rules should applicable to the FpML scheme. If it is not included, it
can be published as separate document with links from the values
description.
3. Generic product: GS uses a very skinny representation for complex
products. Agreement that there are benefits on including this generic
product. There is an open question on whether a more optional
representation based on the confirmation view is better than a generic
representation. Brian mentioned that from his experience, in some cases,
the data is so poor that it is even hard to fill out the elements that
you'd require for generic product. Agreement to include generic product
for reconciliation. Need to update elements based on the analysis that
Brian did.
AOB
Issues with choreography and fixing identities. We'll talk about it in
the next meeting. People can continue discussions in the mailing list.
Actions
=======
MG Check with validation Working group on rationale for not including
validation rules for product type scheme.
BL Update generic product representation.
Kind Regards,
-Marc
+13472846531
**************************************************************************************************************************
The information contained in either this email and, if applicable, the
attachment, are confidential and are intended only for the recipient. The
contents of either the email or the attachment may not be disclosed or
used by anyone other than the addressee. If you are not the intended
recipient(s), any use, disclosure, copying, or distribution is prohibited
and may be unlawful. If you have received this communication in error,
please notify us by e-mail at isda@xxxxxxxx then delete the e-mail and all
attachments and any copies thereof. This communication is part of an ISDA
process and is not intended for unauthorized use or distribution.
**************************************************************************************************************************
-------------------------------------------------------------------------------
To unsubscribe: Email majordomo@xxxxxxxx with a blank subject line
In the body include the line: unsubscribe bpwg youremail@address
To view archives: http://www.fpml.org/_wgmail/_bpwgmail/threads.html
-----------------------------------------
This communication is for informational purposes only. It is not
intended as an offer or solicitation for the purchase or sale of
any financial instrument or as an official confirmation of any
transaction. All market prices, data and other information are not
warranted as to completeness or accuracy and are subject to change
without notice. Any comments or statements made herein do not
necessarily reflect those of JPMorgan Chase & Co., its subsidiaries
and affiliates.
This transmission may contain information that is privileged,
confidential, legally privileged, and/or exempt from disclosure
under applicable law. If you are not the intended recipient, you
are hereby notified that any disclosure, copying, distribution, or
use of the information contained herein (including any reliance
thereon) is STRICTLY PROHIBITED. Although this transmission and any
attachments are believed to be free of any virus or other defect
that might affect any computer system into which it is received and
opened, it is the responsibility of the recipient to ensure that it
is virus free and no responsibility is accepted by JPMorgan Chase &
Co., its subsidiaries and affiliates, as applicable, for any loss
or damage arising in any way from its use. If you received this
transmission in error, please immediately contact the sender and
destroy the material in its entirety, whether in electronic or hard
copy format. Thank you.
Please refer to http://www.jpmorgan.com/pages/disclosures for
disclosures relating to UK legal entities.
-------------------------------------------------------------------------------
To unsubscribe: Email majordomo@xxxxxxxx with a blank subject line
In the body include the line: unsubscribe bpwg youremail@address
To view archives: http://www.fpml.org/_wgmail/_bpwgmail/threads.html